Profitability Ratios
| Ratio |
Value |
| GP Margin |
0.0% |
| EBIT Margin |
0.0% |
| EBITDA Margin |
0.0% |
| Operating Margin |
0.0% |
| Pretax Margin |
0.0% |
| Cont. Ops Margin |
0.0% |
| Net Margin |
0.0% |
| Bottom Line Margin |
0.0% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
7.14 |
| Quick Ratio |
7.14 |
| Solvency Ratio |
-1.541 |
| Cash Ratio |
1.32 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.20 |
| Forward PEG |
-0.20 |
| Price/Book |
9.28 |
| Price/Sales |
0.00 |
| Price/FCF |
-16.57 |
| Price/Op Cash Flow |
-16.87 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0674 |
| Debt/Equity |
0.0973 |
| Debt/Capital |
0.0887 |
| Long-Term Debt/Capital |
0.0802 |
| Financial Leverage |
1.44 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.00 |
| Operating Cash Flow Ratio |
-3.091 |
| Operating Cash Flow/Sales |
0.0% |
| Free Cash Flow/Operating Cash Flow |
101.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-45.00 |
| Interest Coverage |
-48.7957 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
-5.66 |
| Capital Expenditure Coverage |
-56.14 |
| Dividend + Capital Expenditure Coverage |
-56.14 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
0.00 |
| EPS |
-5.950 |
| Debt/Share |
0.9622 |
| Cash/Share |
10.65 |
| Book Value/Share |
8.58 |
| Tangible BV/Share |
8.21 |
| Equity/Share |
8.58 |
| Operating Cash Flow/Share |
-4.722 |
| Capital Expenditure/Share |
0.084 |
| FCF/Share |
-4.806 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.000 |
| Earnings Before Tax/EBIT |
0.957 |
| Price/Fair Value |
9.28 |
| Debt/Market Cap |
0.0094 |
| Effective Tax Rate |
0.0% |
| Enterprise Value Multiple |
-13.68 |
RVMDW - Revolution Medicines, Inc. Warrant